ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Validation of a Blood and Biopsy Gene Expression-Based Molecular Diagnostics for Subclinical Acute Rejection: Comparing DNA Microarrays Vs. Next-Generation RNA Sequencing

    S. Kurian,1 J. Friedewald,2 F. Harrison,1 T. Gelbart,1 S. Head,1 P. Ordoukhanian,1 M. Abecassis,2 D. Salomon.1

    1The Scripps Research Institute, La Jolla, CA; 2Northwestern University, Chicago, IL.

    Background: Microarray-based gene expression signatures for clinical diagnostics are well described. However, microarrays lack advantages offered by newer technologies such as Next Generation Sequencing (NGS):…
  • 2015 American Transplant Congress

    Urinary Cell-Free DNA Is a Sensitive Marker of Early Renal Transplant Injury

    T. Sigdel, T. Tran, S.-C. Hsieh, M. Sarwal.

    Surgery, UC San Francisco, San Francisco, CA.

    Introduction:Circulating donor-derived cell-free DNA (dd-cfDNA) has been reported as a surrogate of transplant injury in the blood but requires expensive donor and recipient DNA sequencing.Method:…
  • 2015 American Transplant Congress

    Mononuclear Cell Infiltrates Characterization in Scar Tissue from a Bilateral Forearm Transplant Patient: Findings to Think

    J. Furuzawa-Carballeda,1 M. Iglesias,2 J. Alberu,3 A. Gamboa,4 P. Butrón,2 M. Morán-Romero,2 Y. Esquivel.1

    1Immunology, INCMNSZ, Mexico City, Mexico; 2Plastic Surgery, INCMNSZ, Mexico, Mexico; 3Transplants, INCMNSZ, Mexico, Mexico; 4Pathology, INCMNSZ, Mexico City, Mexico.

    Herein we report the cell infiltrating pattern in scar tissue resected at the junction of the VCA and the tissue corresponding to the recipient arm,…
  • 2015 American Transplant Congress

    The Predictive Value of the Proliferation Marker Ki-67 in Patients With Fulminant Hepatic Failure

    A. Shah,1 U. Joneja,2 D. Walls,1 J. Farber.2

    1Surgery, Thomas Jefferson University, Philadelphia, PA; 2Pathology, Thomas Jefferson University, Philadelphia, PA.

    This study aimed to evaluate the prognostic significance of the cellular proliferation marker Ki-67 in the liver biopsies of patients with fulminant hepatic failure.Under IRB…
  • 2015 American Transplant Congress

    IgM+ Antigen Binding B Cells in Peripheral Blood Regulate IFNγ Production in Response to HLA Proteins

    L. McLaughlin,1 K. Shiu,1 G. Lombardi,1 J. Spencer,2 R. Vaughan,1 A. Dorling.1

    1MRC Centre for Transplantation, King's College London, London, United Kingdom; 2Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom.

    Chronic antibody mediated rejection (CAMR) is a major cause of graft loss in renal transplant recipients. Previous work utilising an IFNγ ELISPOT assay revealed two…
  • 2015 American Transplant Congress

    Association Between the Timed Up and Go Test and Waitlisting for Kidney Transplantation

    M. Chiles,1 K. Foley,1 R. Crew,1 G. Dube,1 H. Morris,1 S. Patel,2 J. Camacho,2 D. Cohen,1 L. Ratner,2 S. Mohan.1

    1Department of Medicine, Columbia University College of Physicians & Surgeons, New York, NY; 2Department of Surgery, Columbia University College of Physicians & Surgeons, New York, NY.

    Introduction: The Timed Up and Go Test (TUGT) is a test of balance, mobility and functional capacity. Longer times on the TUGT are associated with…
  • 2015 American Transplant Congress

    Kidney Transplantation from Expanded Criteria Deceased Donors With Terminal Acute Kidney Injury

    J. Hwang,1 M.-H. Kim,1 K. Jun,1 S. Ahn,1 S. Kim,1 S. Park,1 S. Kim,2 J. Kim,1 C. Yang,2 I. Moon.1

    1Surgery, The catholic University of Korea, Seoul, Korea; 2Internal Medicine, The catholic iniversity of Korea, Seoul, Korea.

    We investigated clinical outcomes of kidney transplantation (KT) from deceased donors with terminal acute kidney injury (AKI) defined acute kidney injury network (AKIN) criteria and…
  • 2015 American Transplant Congress

    Alemtuzumab Induction Is Associated With a Lower Risk of Early Rehospitalization After Kidney Transplant

    G. Dube,1 D. Tsapepas,2 Y. Coppleson,3 L. Ratner,4 D. Cohen,1 S. Mohan.1

    1Medicine, Columbia University Medical Center, New York, NY; 2Pharmacy, New York-Presbyterian Hospital, New York, NY; 3Quality and Patient Safety, New York-Presbyterian Hospital, New York, NY; 4Surgery, Columbia University Medical Center, New York, NY.

    Early rehospitalizations within the first 30 days (R-30D) are common after kidney transplant. R-30D are costly and associated with an increased risk of graft failure…
  • 2015 American Transplant Congress

    Does Infection Impact On Tacrolimus Blood Levels in Kidney Transplant Recipients?

    N. Kanaan,1 C. Percy,1 Z. Hassoun,2 M. Mourad,3 C. Beguin,4 M. De Meyer,3 E. Goffin.1

    1Nephrology, Cliniques Universitaires Saint Luc, Brussels, Belgium; 2Gastroenterology, Cliniques Universitaires Saint Luc, Brussels, Belgium; 3Abdominal Surgery and Transplantation, Cliniques Universitaires Saint Luc, Brussels, Belgium; 4Medical Information and Statistics, Cliniques Universitaires Saint Luc, Brussels, Belgium.

    Background Tacrolimus (Tac) is the cornerstone of immunosuppressive therapy in kidney transplant recipients. It is metabolized by members of the cytochrome p450 (CYP) 3A subfamily…
  • 2015 American Transplant Congress

    Efficacy and Safety of Desensitization Protocol Based On Rituximab Plus MMF in ABO-Incompatible Kidney Transplantation Without Splenectomy

    K. Takahashi,1 K. Saito,2 S. Takahara,3 S. Fuchinoue,4 T. Yagisawa,5 A. Aikawa,6 Y. Watarai,7 N. Yoshimura,8 K. Tanabe,4 K. Morozumi,9 M. Shimazu.10

    1Niigata Organ Transplant Foundation, Niigata, Japan; 2Graduate School of Medical & Dental Sciences, Niigata University, Niigata, Japan; 3Osaka University Graduate School of Medicine, Osaka, Japan; 4Tokyo Women's Medical University, Tokyo, Japan; 5Jichi Medical University Hospital, Tochigi, Japan; 6Toho University, Faculty of Medicine, Tokyo, Japan; 7Nagoya Daini Red Cross Hospital, Aichi, Japan; 8Kyoto Prefectural University of Medicine, Kyoto, Japan; 9Masuko Memorial Hospital, Aichi, Japan; 10Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.

    Purpose: An open-label, single arm, multicenter clinical study has been conducted in Japan for prospective examination of the efficacy and safety of desensitization protocol with…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences